Literature DB >> 27063387

Improving classification of psychoses.

Stephen M Lawrie1, Michael C O'Donovan2, Elyn Saks3, Tom Burns4, Jeffrey A Lieberman5.   

Abstract

Psychosis has been recognised as an abnormal state in need of care throughout history and by diverse cultures. Present classifications of psychotic disorder remain based on the presence of specific psychotic symptoms, relative to affective and other symptoms, and their sequence and duration. Although extant diagnostic classifications have restricted validity, they have proven reliability and most clinicians and some patients find them useful. Moreover, these classifications have yet to be replaced by anything better. We propose that an expansion of the subgrouping approach inherent to classification will provide incremental improvement to present diagnostic constructs-as has worked in the rest of medicine. We also propose that subgroups could be created both within and across present diagnostic classifications, taking into consideration the potential value of continuous measures (eg, duration of psychotic symptoms and intelligence quotient). Health-care workers also need to work with service users and carers to develop and adapt approaches to diagnosis that are seen as helpful.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27063387     DOI: 10.1016/S2215-0366(15)00577-5

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN: 2215-0366            Impact factor:   27.083


  10 in total

1.  Conceptualizing psychotic disorders: don't throw the baby out with the bathwater.

Authors:  Rajiv Tandon
Journal:  World Psychiatry       Date:  2016-06       Impact factor: 49.548

2.  Research Domain Criteria: Strengths, Weaknesses, and Potential Alternatives for Future Psychiatric Research.

Authors:  Christopher A Ross; Russell L Margolis
Journal:  Mol Neuropsychiatry       Date:  2019-08-13

Review 3.  Aberrant glycosylation in schizophrenia: a review of 25 years of post-mortem brain studies.

Authors:  Sarah E Williams; Robert G Mealer; Edward M Scolnick; Jordan W Smoller; Richard D Cummings
Journal:  Mol Psychiatry       Date:  2020-05-13       Impact factor: 15.992

4.  Transdiagnostic psychiatry: a systematic review.

Authors:  Paolo Fusar-Poli; Marco Solmi; Natascia Brondino; Cathy Davies; Chungil Chae; Pierluigi Politi; Stefan Borgwardt; Stephen M Lawrie; Josef Parnas; Philip McGuire
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

Review 5.  Glycobiology and schizophrenia: a biological hypothesis emerging from genomic research.

Authors:  Robert G Mealer; Sarah E Williams; Mark J Daly; Edward M Scolnick; Richard D Cummings; Jordan W Smoller
Journal:  Mol Psychiatry       Date:  2020-05-06       Impact factor: 15.992

Review 6.  Nosology and Phenomenology of Psychosis in Movement Disorders.

Authors:  Malco Rossi; Nicole Farcy; Sergio E Starkstein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2020-01-07

7.  Quantitative exploration of factors influencing psychotic disorder ailments in Nigeria.

Authors:  Adebowale O Adejumo; Nehemiah A Ikoba; Esivue A Suleiman; Hilary I Okagbue; Pelumi E Oguntunde; Oluwole A Odetunmibi; Obalowu Job
Journal:  Data Brief       Date:  2017-07-24

Review 8.  Antipsychotic Drug Development: From Historical Evidence to Fresh Perspectives.

Authors:  Katrina Weston-Green
Journal:  Front Psychiatry       Date:  2022-06-16       Impact factor: 5.435

9.  Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk and the Prediction of Psychosis: Second Replication in an Independent National Health Service Trust.

Authors:  Paolo Fusar-Poli; Nomi Werbeloff; Grazia Rutigliano; Dominic Oliver; Cathy Davies; Daniel Stahl; Philip McGuire; David Osborn
Journal:  Schizophr Bull       Date:  2019-04-25       Impact factor: 9.306

10.  Clinical-learning versus machine-learning for transdiagnostic prediction of psychosis onset in individuals at-risk.

Authors:  Paolo Fusar-Poli; Dominic Stringer; Alice M S Durieux; Grazia Rutigliano; Ilaria Bonoldi; Andrea De Micheli; Daniel Stahl
Journal:  Transl Psychiatry       Date:  2019-10-17       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.